Clinical trial

Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II…

NCT00190541 · Haruhiko Fukuda, Other · Completed

Key facts

NCT number NCT00190541
Title Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)
Official title Mesorectal Excision With Lateral Lymph Node Dissection Versus Without Lateral Lymph Node Dissection for Clinical Stage II, III Lower Rectal Cancer (JCOG0212)
Lead sponsor Haruhiko Fukuda, Other
Collaborators Ministry of Health, Labour and Welfare, Japan
Status Completed
Phase Phase 3
Study type Interventional
Conditions Rectal Neoplasms
Intervention type Procedure
Interventions Mesorectal excision with lateral lymph node dissection, Mesorectal excision without lateral lymph node excision
Enrollment 700
Start date Jun 1, 2003
Primary completion Jun 1, 2015
Completion Jun 1, 2015
First posted Sep 19, 2005
Last update posted Sep 22, 2016
Countries Japan

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies